T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

Jeffrey M. Critchfield; Michael K. Racke; Juan Carlos Zúñiga-Pflücker; Barbara Cannella; Cedric S. Raine; Joan Goverman; Michael J. Lenardo

doi:10.1126/science.7509084

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

Jeffrey M. Critchfield, Michael K. Racke, Juan Carlos Zúñiga-Pflücker, Barbara Cannella, Cedric S. Raine, Joan Goverman, Michael J. Lenardo

Research output: Contribution to journal › Article › peer-review

497 Scopus citations

Abstract

Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.

Original language	English (US)
Pages (from-to)	1139-1143
Number of pages	5
Journal	Science
Volume	263
Issue number	5150
DOIs	https://doi.org/10.1126/science.7509084
State	Published - 1994
Externally published	Yes

ASJC Scopus subject areas

General

Access to Document

10.1126/science.7509084

Cite this

@article{b7e50cd38b7f4d30a426db254665d8f9,

title = "T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis",

abstract = "Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.",

author = "Critchfield, {Jeffrey M.} and Racke, {Michael K.} and Z{\'u}{\~n}iga-Pfl{\"u}cker, {Juan Carlos} and Barbara Cannella and Raine, {Cedric S.} and Joan Goverman and Lenardo, {Michael J.}",

year = "1994",

doi = "10.1126/science.7509084",

language = "English (US)",

volume = "263",

pages = "1139--1143",

journal = "Science",

issn = "0036-8075",

publisher = "American Association for the Advancement of Science",

number = "5150",

}

TY - JOUR

T1 - T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

AU - Critchfield, Jeffrey M.

AU - Racke, Michael K.

AU - Zúñiga-Pflücker, Juan Carlos

AU - Cannella, Barbara

AU - Raine, Cedric S.

AU - Goverman, Joan

AU - Lenardo, Michael J.

PY - 1994

Y1 - 1994

N2 - Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.

AB - Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.

UR - http://www.scopus.com/inward/record.url?scp=0028215537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028215537&partnerID=8YFLogxK

U2 - 10.1126/science.7509084

DO - 10.1126/science.7509084

M3 - Article

C2 - 7509084

AN - SCOPUS:0028215537

SN - 0036-8075

VL - 263

SP - 1139

EP - 1143

JO - Science

JF - Science

IS - 5150

ER -

T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this